{"chunk_id": "medquad__chunk_33292", "source": "medquad", "text": "Vigabatrin (Sabril) has been approved by the U.S. Food and Drug Administration to treat infantile spasms in children ages one month to two years. Some children have spasms as the result of brain lesions, and surgical removal of these lesions may result in improvement.\",NINDS,Infantile Spasms\nWhat is the outlook for Infantile Spasms ?,\"The prognosis for children with IS is dependent on the underlying causes of the seizures. The intellectual prognosis for children with IS is generally poor becaus"}